Back to Companies
Corvus Pharmaceuticals, Inc.
CRVSNasdaqCIK: 0001626971
Over the 14 most recent insider filings, Corvus Pharmaceuticals, Inc. (CRVS) has seen activity from 10 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $250.2K bought versus $0 sold, a net purchase of $250.2K. MILLER RICHARD A MD is the most active by dollar volume, and the single largest transaction was $8.8M by MILLER RICHARD A MD. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$20.8M
Purchases
$250.2K
Sales
$0
Unique Insiders
10
Recent Insider Trades
14 loaded
| Jun 15 | CRVS Corvus Pharmaceuticals, Inc. | Grais Linda | Insider | Award | $174.0K |
| Jun 15 | CRVS Corvus Pharmaceuticals, Inc. | CLARK IAN T | Insider | Award | $174.0K |
| Jun 15 | CRVS Corvus Pharmaceuticals, Inc. | van den Broek Richard | Insider | Award | $174.0K |
| Jun 15 | CRVS Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Insider | Award | $174.0K |
| Jun 15 | CRVS Corvus Pharmaceuticals, Inc. | Moore David Scott | Insider | Buy | $250.2K |
| Apr 27 | CRVS Corvus Pharmaceuticals, Inc. | Chan Andrew C. | Insider | Award | $480.6K |
| Apr 27 | CRVS Corvus Pharmaceuticals, Inc. | Chan Andrew C. | Insider | Other | $0 |
| Jan 30 | CRVS Corvus Pharmaceuticals, Inc. | Thompson Peter A. | Director, 10% Owner | Exercise | $2.2M |
| Dec 8 | CRVS Corvus Pharmaceuticals, Inc. | Arcara Jeffrey | Insider | Award | $881.0K |
| Dec 8 | CRVS Corvus Pharmaceuticals, Inc. | LEA LEIV | Insider | Award | $3.5M |
| Dec 8 | CRVS Corvus Pharmaceuticals, Inc. | Jones William Benton | Insider | Award | $3.5M |
| Dec 8 | CRVS Corvus Pharmaceuticals, Inc. | MILLER RICHARD A MD | Insider | Award | $8.8M |
| Oct 6 | CRVS Corvus Pharmaceuticals, Inc. | Moore David Scott | Insider | Award | $211.2K |
| Oct 6 | CRVS Corvus Pharmaceuticals, Inc. | Moore David Scott | Insider | Other | $0 |
14 filings